FWM
CYTK icon

Focused Wealth Management’s Cytokinetics CYTK Stock Holding History

Focused Wealth Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9
Closed -$412 – 1064
2022
Q4 		$412 Buy
+9
New +$387 ﹤0.01% 968

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Focused Wealth Management's CYTK Position: Q1 2023 in Review

Focused Wealth Management sold out of Cytokinetics (CYTK) in Q1 2023, closing a stake of 9 shares — an estimated $412 sold.

Focused Wealth Management first reported a position in CYTK in Q4 2022 and held it in 1 quarter. The position peaked at $412 in Q4 2022. 262 funds tracked by Wall St. Rank hold CYTK as of Q1 2023.

  • Focused Wealth Management reported no remaining Cytokinetics position as of Q1 2023 after selling out during the quarter.
  • Focused Wealth Management sold 9 Cytokinetics shares in Q1 2023, an estimated $412.
  • Focused Wealth Management first reported a position in Cytokinetics in Q4 2022 and held it in 1 quarter.
  • Focused Wealth Management's Cytokinetics position peaked at $412 in Q4 2022.
  • 262 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2023.

Based on Focused Wealth Management's 13F filing for Q1 2023, filed 13 Apr 2023.